Study guide

9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens

Key Takeaways Explain This Topic AI

The red complex is Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola, associated with pockets of 6 mm or more and active attachment loss.

Gingipains degrade host proteins, including complement components, and liberate peptides and haem for bacterial nutrition.

Porphyromonas gingivalis lipopolysaccharide can act as a TLR4 antagonist, allowing immune evasion.

The keystone pathogen hypothesis holds that P. gingivalis at low abundance remodels the commensal community into a dysbiotic consortium through C5aR1-TLR2 crosstalk.

Last updated: September 2026

  • 4. Microbial Pathogenesis: Complexes, Keystone Pathogens, and Virulence
  • Socransky Microbial Complexes

In 1998, Sigmund Socransky and colleagues utilized whole-genomic DNA probes and checkerboard DNA-DNA hybridization to categorize subgingival plaque into six distinct microbial complexes based on their ecological succession and association with periodontal health versus disease: [Early Colonisers: Yellow, Green, Purple, Blue Complexes]

  • (Streptococcus spp., Actinomyces spp., Capnocytophaga spp.)
  • │
  • ▼ (Bridging by Orange Complex: Fusobacterium nucleatum)
  • [Intermediate Colonisers: Orange Complex]
  • (Prevotella intermedia, Parvimonas micra, Campylobacter rectus)
  • │
  • ▼ (Environmental Shift: Anaerobic, Asaccharolytic, Proteolytic)
  • [Late Colonisers: Red Complex (True Periodontal Pathogens)]
  • (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola)

Complex Representative Bacterial Species Ecological Role & Clinical Association

Yellow Streptococcus gordonii , S. mitis , S. oralis , S. sanguinis Early colonisers; adhere to salivary pellicle via statherin and proline-rich proteins; primary health-associated flora.

Blue Actinomyces naeslundii , Actinomyces viscosus Early colonisers; co-aggregate with streptococci; establish structural biofilm scaffolding.

Purple Veillonella parvula , Actinomyces odontolyticus Early colonisers; utilize metabolic by-products (lactic acid) produced by streptococci.

Green Eikenella corrodens , Capnocytophaga gingivalis Intermediate colonisers; capnophilic; associated with healthy sites and localized gingival lesions.

Orange Fusobacterium nucleatum , Prevotella intermedia , Parvimonas micra , Campylobacter rectus Bridging species ; co-aggregate with both early Gram-positive colonisers and late anaerobes via surface adhesins (RadD, Fap2); correlates with increasing pocket depth and precedes Red Complex emergence.

Red Porphyromonas gingivalis , Tannerella forsythia , Treponema denticola Consortium of periodontal pathogens ; obligate anaerobes, strictly proteolytic and asaccharolytic; strongly correlated with pockets ≥ 6 mm, active attachment loss, and bleeding on probing.

Virulence Factors of Porphyromonas gingivalis

Porphyromonas gingivalis is an obligate anaerobic, Gram-negative, black-pigmented coccobacillus that possesses a sophisticated repertoire of virulence determinants:

Gingipains (RgpA, RgpB, and Kgp): Surface-anchored and secreted cysteine endopeptidases that are specific for arginine (RgpA, RgpB) or lysine (Kgp) peptide bonds.

Tissue degradation: Degrade host extracellular matrix components, including native Type I and Type III collagen, fibronectin, and laminin.

Complement subversion: Cleave complement components C3 and C5, releasing C5a without generating lytic C5b-9 membrane attack complexes (MACs), thus driving inflammation while avoiding bacterial killing.

Immunoglobulin degradation: Cleave host IgG and secretory IgA antibodies, disarming adaptive humoral surveillance.

Nutrient acquisition: Kgp digests haemoglobin to release haemin, which P. gingivalis accumulates on its outer membrane as iron protoporphyrin IX, yielding its signature black pigmentation on blood agar plates and providing essential iron for its anaerobic electron transport.

Fimbriae (Pili):

Major Fimbriae (FimA): Mediate initial adhesion to salivary statherin, proline-rich proteins, and cell-surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) on early colonizers like Streptococcus gordonii .

Minor Fimbriae (Mfa1): Mediate cell-to-cell co-aggregation with Treponema denticola and other subgingival species.

Lipopolysaccharide (LPS) Heterogeneity: Unlike typical enteric Gram-negative bacteria whose LPS consistently activates TLR4, P. gingivalis produces an atypical, heterogeneous lipid A structure with both tetra-acylated and penta-acylated forms. The tetra-acylated isoform can function as a competitive TLR4 antagonist , dampening local immune alarm, whereas the penta-acylated isoform engages TLR2 , orchestrating chronic low-grade inflammation.

Polysaccharide Capsule: K-antigen polysaccharide capsule confers resistance to complement-mediated opsonisation, reduces phagocytic uptake by neutrophils, and enhances bacterial survival within soft tissues.

The Keystone Pathogen Hypothesis (Hajishengallis & Lamont)

Historically, periodontitis was viewed through the lens of Socransky's Red Complex as a polymicrobial infection where tissue damage scaled with the absolute abundance of P. gingivalis , T. forsythia , and T. denticola . However, contemporary molecular epidemiology revealed that P. gingivalis frequently constitutes less than 0.1–1.0% of the total microbial count even in sites of active periodontitis.

In 2012, George Hajishengallis, Richard Lamont, and colleagues proposed the Keystone Pathogen Hypothesis . Analogous to a keystone species in macro-ecology, P. gingivalis can exert a profound, disproportionate remodeling effect on its entire ecological community despite its low numerical abundance. It transforms a benign, symbiotic commensal community into a dysbiotic, disease-provoking consortium :

Mechanistic Basis — C5aR1-TLR2 Crosstalk: P. gingivalis gingipains (RgpA) enzymatically cleave host complement component C5 to generate active C5a . C5a binds to the G-protein coupled receptor C5aR1 on macrophages and neutrophils. Concurrently, P. gingivalis engages surface TLR2 .

This simultaneous engagement of C5aR1 and TLR2 triggers intracellular cross-talk that activates phosphoinositide 3-kinase ( PI3K ). Active PI3K blocks the small GTPase RhoA , which paralyzes actin polymerisation and halts phagocytosis and phagosomal maturation .

Crucially, while bactericidal killing is disabled, the pro-inflammatory signaling cascade is not blocked: PI3K signaling synergises with TLR2 to hyper-activate the NF-κB pathway, sustaining a relentless release of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6).

Commensal bacteria within the biofilm are shielded from host phagocytic clearance while being continuously nourished by inflammatory tissue breakdown products (collagen fragments, iron, haem), resulting in community-wide dysbiosis.

What the Complexes Do and Do Not Tell You

The Socransky complexes describe association , not causation. Red complex organisms — Porphyromonas gingivalis , Tannerella forsythia and Treponema denticola — are strongly associated with deep, bleeding pockets, but they are also detectable at low levels in healthy sites, and their eradication is neither achievable nor necessary for a successful clinical outcome. This is the reason routine microbiological sampling is not recommended in UK general practice: the result would not change the treatment, which remains mechanical disruption of the biofilm with risk factor control.

The orange complex, including Fusobacterium nucleatum and Prevotella intermedia , matters because F. nucleatum acts as the bridging organism that co-aggregates with both early and late colonisers and so permits the transition from an early, largely Gram-positive aerobic community to a mature, Gram-negative anaerobic one. Remove the biofilm regularly and that succession never completes — which is the entire scientific rationale for supragingival plaque control and for supportive periodontal care intervals.